Schizophrenia

The agency will start auditing nursing homes this month to determine whether residents’ schizophrenia diagnoses are accurate and appropriately coded. A pattern of inaccurate coding may result in a quality...

The Centers for Medicare & Medicaid Services will be increasing its oversight of the use of psychotropic drugs to pay closer attention to certain classes, warned the lead author of a federal report identifying...

Makers of new class of schizophrenia drug expect to file for FDA approval … Precancerous skin lesions common among Medicare beneficiaries: study … Triple therapy halves mortality in patients with severe...

SNF directors of nursing say this influx of untraditional residents, many of whom have no appropriate discharge setting, poses care challenges.

The rate of schizophrenia diagnoses rose significantly for Black nursing home residents with dementia after the CMS National Partnership to Improve Dementia Care launched in 2012, a new analysis finds.

At least one-fifth of nursing home residents are taking the drugs, many for schizophrenia, a diagnosis that has skyrocketed in these settings since 2012, a new investigation finds.

Parkinsonism linked to significantly decreased physical activity, increased sedentary behavior in patients with schizophrenia

The Minimum Data Set should not be CMS’ sole source for determining the number of nursing home residents using antipsychotic drugs, according to a new report from HHS’ Office of the Inspector General.

Antipsychotic drug lumateperone improves schizophrenia symptoms without side effects such as weight gain and metabolic disturbance.

A Chicago psychiatrist is accused of submitting $190,000 in false claims to Medicare and Medicaid and receiving kickbacks for prescribing antipsychotics.